Clinical trials
Phase 2 Alzheimer Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
| Completed | 4 |
| Recruiting | 4 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fujian Medical University Union Hospital | 3 |
| Capital Medical University | 2 |
| Beijing Joekai Biotechnology LLC | 1 |
| Celgene | 1 |
| Changchun Huayang High-tech Co., Ltd | 1 |
| ChenXiaoChun | 1 |
| Dongzhimen Hospital, Beijing | 1 |
| First Affiliated Hospital of Fujian Medical University | 1 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 18 |
| Cognitive Dysfunction | 4 |
| Dementia | 1 |
| Hypotension, Orthostatic | 1 |
| Psychomotor Agitation | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.